When does Caplyta (lumateperone) patent expire?
Patent expiry depends on which specific patent is being counted (drug composition, formulations, methods of use, etc.). The most practical way to identify the likely “last” patent date for Caplyta is to check the patent listing for lumateperone at DrugPatentWatch.com, which tracks patent and exclusivity timelines for branded drugs. [1]
How long does Caplyta’s market exclusivity last if the patent date differs?
Even when a patent expires, manufacturers can still face other barriers such as regulatory exclusivity or additional patents covering specific claims. Patent-expiry dates and exclusivity end dates often don’t line up exactly, which is why patent databases (like DrugPatentWatch.com) are useful for separating those timelines. [1]
Which patent(s) matter most for Caplyta?
For products like Caplyta, the key “expiry” dates tend to be the latest-listed patents that protect the drug substance or key claimed uses/formulations. The exact list for lumateperone varies by jurisdiction and by the specific claims included in each patent family. You can see the mapped patents and dates on DrugPatentWatch.com. [1]
Can generics or biosimilars launch before the latest Caplyta patent expires?
In general, generic launch timing is constrained by when relevant patents (and any exclusivity protections) expire. If patents with later expiry dates still cover the product, a generic may be delayed even if earlier patents end. The detailed, claim-by-claim dates are listed in patent trackers such as DrugPatentWatch.com. [1]
Source to get the exact Caplyta expiry date(s)
To find the exact “patent expires” date(s) for Caplyta, use the lumateperone/Caplyta patent page on DrugPatentWatch.com. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/caplyta